Headlines about National Health Investors (NYSE:NHI) have trended somewhat positive this week, according to Accern. The research group identifies negative and positive media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. National Health Investors earned a coverage optimism score of 0.15 on Accern’s scale. Accern also assigned media stories about the real estate investment trust an impact score of 46.0715035333527 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Shares of National Health Investors (NHI) traded up $0.04 during mid-day trading on Friday, hitting $78.15. The company had a trading volume of 107,467 shares, compared to its average volume of 209,514. The company has a current ratio of 12.72, a quick ratio of 12.72 and a debt-to-equity ratio of 0.84. The company has a market capitalization of $3,244.08, a PE ratio of 14.99, a P/E/G ratio of 3.86 and a beta of 0.58. National Health Investors has a fifty-two week low of $68.75 and a fifty-two week high of $81.21.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 31st. Investors of record on Friday, December 29th will be paid a $0.95 dividend. This represents a $3.80 annualized dividend and a dividend yield of 4.86%. The ex-dividend date of this dividend is Thursday, December 28th. National Health Investors’s dividend payout ratio (DPR) is currently 95.00%.

NHI has been the topic of several research reports. Zacks Investment Research raised National Health Investors from a “hold” rating to a “buy” rating and set a $89.00 target price on the stock in a research report on Friday, September 15th. Mizuho reaffirmed a “hold” rating and issued a $82.00 target price on shares of National Health Investors in a research report on Wednesday, October 4th. SunTrust Banks, Inc. began coverage on National Health Investors in a research report on Tuesday, October 10th. They issued a “hold” rating and a $80.00 target price on the stock. BidaskClub upgraded National Health Investors from a “sell” rating to a “hold” rating in a research note on Thursday, August 17th. Finally, KeyCorp reiterated a “hold” rating on shares of National Health Investors in a research note on Sunday, September 17th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and two have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $80.14.

TRADEMARK VIOLATION NOTICE: This article was first published by Watch List News and is owned by of Watch List News. If you are reading this article on another website, it was stolen and reposted in violation of United States & international copyright legislation. The correct version of this article can be read at https://www.watchlistnews.com/national-health-investors-nhi-receiving-somewhat-favorable-press-coverage-study-finds/1726469.html.

National Health Investors Company Profile

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Insider Buying and Selling by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.